Consistent with the in vitro findings, our in vivo experiments in mice with DSS‐induced IBD revealed that the activation of PPARγ could attenuate disease symptoms, such as weight loss, diarrhea, and bloody stool. Here, PPARG is linked to inflammatory bowel disease.